Buch, Englisch, 172 Seiten, Format (B × H): 183 mm x 260 mm, Gewicht: 567 g
Reihe: Neuromethods
Buch, Englisch, 172 Seiten, Format (B × H): 183 mm x 260 mm, Gewicht: 567 g
Reihe: Neuromethods
ISBN: 978-1-0716-4782-0
Verlag: Humana
This volume discusses that latest cell therapy methods for neurological diseases using bone marrow-derived mononuclear cells, mesenchymal stem cells, dental pulp stem cells, adipose-derived stem cells, cord blood cells, and amnion cells. The chapters in this book also cover specific diseases such as cerebral infarction, spinal cord injury, amyotrophic lateral sclerosis, neuropathic pain, and hypoxic-ischemic encephalopathy. Each chapter includes a detailed description of the protocol for preparing the cells used, the method for producing the animals used, and the characteristics of patients with each disease, as well as an explanation of the behavioral experiments, molecular biochemical experiments, and other methods required to evaluate the effectiveness of the treatment. In the series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory.
Cutting-edge and practical, is a valuable resource for graduate students and postdoctoral researchers who want to learn more about this field and develop cell therapies for neurological diseases.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
Bone Marrow-Derived Mononuclear Cells for Stroke.- Autologous Mesenchymal Stem Cells Derived from Adipose Tissue for Acute Spinal Cord Injury.- Bone Marrow-Derived Mononuclear Cells for Spinal Cord Injury.- Bone Marrow-Derived Inducible Microglia-Like (BM-iMG) Cells for Amyotrophic Lateral Sclerosis.- Adipose-Derived Stem Cells for Amyotrophic Lateral Sclerosis.- Bone Marrow-Derived Cells with GLT1 Gene Delivery for Amyotrophic Lateral Sclerosis.- Combination Therapy of Bone Marrow-Derived Mononuclear Cells and Mesenchymal Stem Cells Expressing Growth Factors for Amyotrophic Lateral Sclerosis.- Differentiation of Human Dental Pulp Stem Cells (hDPSCs) into GABAergic Neuron-Like Cells for Personalized Cell Therapy.- Bone Marrow-Derived Mononuclear Cells for Neuropathic Pain.- Bone Marrow-Derived Mesenchymal Stromal Cells for Neonatal Hypoxic-Ischemic Encephalopathy in Mice.- Transplantation of Human Cord Blood.- Model of Neonatal Ischemia-Reperfusion Brain Injury.- Human Amnion-Derived Cells for Neonatal Hypoxic-Ischemic Encephalopathy in Mice.
